These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2475191)

  • 1. A dose-dependent effect of recombinant erythropoietin on the reticulocyte population of rats.
    Eder H; Rosslenbroich B; Failing K
    Blut; 1989 Aug; 59(2):184-7. PubMed ID: 2475191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effects of recombinant human erythropoietin on the reticulocyte population of rabbits.
    Fuchs A; Eder H
    Arzneimittelforschung; 1992 Oct; 42(10):1266-8. PubMed ID: 1472149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats.
    Wiczling P; Krzyzanski W; Zychlińska N; Lewandowski K; Kaliszan R
    Biopharm Drug Dispos; 2014 Sep; 35(6):330-40. PubMed ID: 24888906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modification of reticulocyte count and distribution of degree of maturity by erythropoietin in the rat].
    Eder H; Wiemer U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):517-22. PubMed ID: 2446992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects.
    Pérez-Ruixo JJ; Krzyzanski W; Hing J
    Clin Pharmacokinet; 2008; 47(6):399-415. PubMed ID: 18479174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjects.
    Krzyzanski W; Perez-Ruixo JJ
    Pharm Res; 2007 Apr; 24(4):758-72. PubMed ID: 17318417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin acts as a trophic factor in neonatal rat intestine.
    Juul SE; Ledbetter DJ; Joyce AE; Dame C; Christensen RD; Zhao Y; DeMarco V
    Gut; 2001 Aug; 49(2):182-9. PubMed ID: 11454792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men.
    Flaharty KK; Caro J; Erslev A; Whalen JJ; Morris EM; Bjornsson TD; Vlasses PH
    Clin Pharmacol Ther; 1990 May; 47(5):557-64. PubMed ID: 2188770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological evaluation of recombinant human erythropoietin in pharmaceutical products.
    Ramos AS; Schmidt CA; Andrade SS; Fronza M; Rafferty B; Dalmora SL
    Braz J Med Biol Res; 2003 Nov; 36(11):1561-9. PubMed ID: 14576911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocrit.
    Andrews DA; Boren BM; Turk JR; Boyce RW; He YD; Hamadeh HK; Mytych DT; Barger TE; Salimi-Moosavi H; Sloey B; Elliott S; McElroy P; Sinclair AM; Shimamoto G; Pyrah IT; Lightfoot-Dunn RM
    Toxicol Pathol; 2014; 42(3):524-39. PubMed ID: 23674391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of fractionated administration of erythropoietin in splenectomized or shamoperated erythraemic mice.
    Fogh J
    Scand J Haematol; 1974; 12(2):133-46. PubMed ID: 4133854
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients.
    Sowade O; Sowade B; Brilla K; Franke W; Stephan P; Gross J; Scigalla P; Warnke H
    Am J Hematol; 1997 Jun; 55(2):89-96. PubMed ID: 9209004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of reticulocyte maturation after erythropoietin administration in rats.
    Wiczling P; Ait-Oudhia S; Krzyzanski W
    Cytometry A; 2009 Jul; 75(7):584-92. PubMed ID: 19437531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dose, pH and osmolarity on intranasal absorption of recombinant human erythropoietin in rats.
    Shimoda N; Maitani Y; Machida Y; Nagai T
    Biol Pharm Bull; 1995 May; 18(5):734-9. PubMed ID: 7492992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reticulocyte measurements as a bioassay for erythropoietin.
    Barbone AG; Aparicio B; Anderson DW; Natarajan J; Ritchie DM
    J Pharm Biomed Anal; 1994 Apr; 12(4):515-22. PubMed ID: 7918768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel reporter gene assay for recombinant human erythropoietin (rHuEPO) pharmaceutical products.
    Yang Y; Zhou Y; Yu L; Li X; Shi X; Qin X; Rao C; Wang J
    J Pharm Biomed Anal; 2014 Nov; 100():316-321. PubMed ID: 25194345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reticulocyte changes after experimental anemia and erythropoietin treatment of horses.
    Cooper C; Sears W; Bienzle D
    J Appl Physiol (1985); 2005 Sep; 99(3):915-21. PubMed ID: 16103516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rh-erythropoietin stimulates immature reticulocyte release in man.
    Major A; Bauer C; Breymann C; Huch A; Huch R
    Br J Haematol; 1994 Jul; 87(3):605-8. PubMed ID: 7993803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin-induced erythroid precursor pool depletion causes erythropoietin hyporesponsiveness.
    Yan X; Ait-Oudhia S; Krzyzanski W
    Pharm Res; 2013 Apr; 30(4):1026-36. PubMed ID: 23187865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination and physiologic effects of erythropoiesis inhibitors.
    Skjaelaaen P; Halvorsen S
    J Lab Clin Med; 1974 Apr; 83(4):625-33. PubMed ID: 4856344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.